Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sonoma Pharmaceuticals, Inc. - Common Stock (NQ: SNOA )

2.600 -0.060 (-2.26%)
Streaming Delayed Price Updated: 3:59 PM EST, Jan 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 35,369
Open 2.600
Bid (Size) 2.600 (1)
Ask (Size) 2.700 (2)
Prev. Close 2.660
Today's Range 2.540 - 2.660
52wk Range 2.440 - 9.374
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices
Via ACCESSWIRE

Performance

YTD
-2.99%
-2.99%
1 Month
-5.80%
-5.80%
3 Month
-15.58%
-15.58%
6 Month
-66.63%
-66.63%
1 Year
-29.58%
-29.58%

More News

Read More
Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States
Via ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel
Via ACCESSWIRE
Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results
Via ACCESSWIRE
Why Sonoma Pharmaceuticals (SNOA) Stock Is Moving
Via Benzinga
Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf
Via ACCESSWIRE
Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada
Via ACCESSWIRE
Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences
Via ACCESSWIRE
Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule
Via ACCESSWIRE
Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based Solution
Via ACCESSWIRE
Sonoma Pharmaceuticals Reports First Fiscal Quarter 2025 Financial Results
Via ACCESSWIRE
Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product Line
Via ACCESSWIRE
Sonoma Pharmaceuticals Announces 1-for-20 Reverse Split of Outstanding Common Stock
Via ACCESSWIRE
Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn(R) Disinfectant & Sanitizer has been Approved by the Australian TGA as Effective Against Candida auris and C-Diff
Via ACCESSWIRE
Sonoma Pharmaceuticals Announces Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in the United States
Via ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Why Ainos Shares Are Trading Higher By Around 38%; Here Are 20 Stocks Moving Premarket
Via Benzinga
SNOA Stock Earnings: Sonoma Pharmaceuticals Misses EPS, Misses Revenue for Q1 2025
Via InvestorPlace
Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Why Ericsson Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Via Benzinga
Sonoma Pharmaceuticals Celebrates 20 Years of Selling Wound Care Products in Europe and Announces New Distributor in Ukraine
Via ACCESSWIRE
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.